TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 71 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111 | +6.7% | 2,934 | +6.8% | 0.00% | – |
| Q2 2023 | $104 | +55.2% | 2,747 | -0.7% | 0.00% | – |
| Q1 2023 | $67 | -17.3% | 2,766 | -1.4% | 0.00% | – |
| Q4 2022 | $81 | -99.9% | 2,805 | -0.4% | 0.00% | – |
| Q3 2022 | $84,000 | -16.8% | 2,815 | +0.3% | 0.00% | – |
| Q2 2022 | $101,000 | -20.5% | 2,806 | -4.5% | 0.00% | – |
| Q1 2022 | $127,000 | -13.0% | 2,938 | +0.5% | 0.00% | – |
| Q4 2021 | $146,000 | -26.6% | 2,922 | -6.7% | 0.00% | -100.0% |
| Q3 2021 | $199,000 | -17.8% | 3,133 | -6.8% | 0.00% | 0.0% |
| Q2 2021 | $242,000 | -1.6% | 3,360 | +0.8% | 0.00% | 0.0% |
| Q1 2021 | $246,000 | -58.9% | 3,332 | -22.0% | 0.00% | -66.7% |
| Q2 2014 | $599,000 | +25.8% | 4,270 | -0.4% | 0.00% | +50.0% |
| Q1 2014 | $476,000 | +41.7% | 4,287 | +26.2% | 0.00% | 0.0% |
| Q4 2013 | $336,000 | – | 3,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |